Research Associate IV, Biomarker and BioAnalytical Sciences
Sangamo Therapeutics, Inc.
Khaled Hettini is currently a Research Associate IV in the Biomarker and BioAnalytical Sciences group at Sangamo Therapeutics, Inc. His responsibilities include developing and performing biochemical and immunochemical assays to support nonclinical and clinical studies for Gene Therapy, Cell Therapy and Genome Editing programs. Prior to joining Sangamo, Mr. Hettini acquired extensive experience at Genentech in developing PK, biomarker, immunogenicity and functional assays for antibody screening and in vivo studies to evaluate PK/PD, efficacy and safety of large molecule therapeutics in disease areas of Oncology, Autoimmune Disorders and Infectious Disease. Mr. Hettini holds a Bachelor of Science in Biochemistry from California Polytechnic State University, San Luis Obispo and has been in the industry for over eleven years.
Wednesday, October 28, 2020
9:45 AM – 10:00 AM ET